3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Conditions
Wilms Tumor
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hepatoblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Pancreatic Cancer
1
Interventions
Cyclophosphamide
32
Filgrastim
18
Irinotecan
15
Topotecan
14
Temozolomide
13
Vincristine
12
Peripheral Blood Stem Cell Transplantation
12
Granulocyte Colony-Stimulating Factor
12
Etoposide
12
Melphalan
11
fludarabine
10
Carboplatin
9
dinutuximab
8
Isotretinoin
8
Interleukin-2
8
Busulfan
8
humanized 3F8 anti-GD2 monoclonal antibody
7
aldesleukin
7
Doxorubicin
7
3-Iodobenzylguanidine
7
sargramostim
6
fludarabine phosphate
6
Vorinostat
6
Zoledronic Acid
5
Stem Cell Transplantation
5
Cisplatin
5
etoposide phosphate
4
Ipilimumab
4
Drug Therapy
4
ribociclib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Neuroblastoma
×
Simvastatin
×
Clear all
NCT02390843
2020-04-03
AflacST1402
Emory University
Phase 1
Completed
13 enrolled